What is the role of cangrelor in patients undergoing PCI?

Droppa, Michal; Geisler, Tobias

dc.contributor.author	Droppa, Michal
dc.contributor.author	Geisler, Tobias
dc.date.accessioned	2020-01-15T13:24:32Z
dc.date.available	2020-01-15T13:24:32Z
dc.date.issued	2018
dc.identifier.issn	1875-6212
dc.identifier.uri	http://hdl.handle.net/10900/96982
dc.language.iso	en	de_DE
dc.publisher	Bentham Science Publ Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2174/1570161116666180117105834	de_DE
dc.subject.ddc	610	de_DE
dc.title	What is the role of cangrelor in patients undergoing PCI?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_04225
utue.publikation.seiten	484-489	de_DE
utue.personen.roh	Droppa, Michal
utue.personen.roh	Geisler, Tobias
dcterms.isPartOf.ZSTitelID	Current Vascular Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE